D.R. Horton
DHI
Strategy
MSTR
Meritage Homes
MTH
4
KB Home
KBH
5
Taylor Morrison Home
TMHC
US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 36.530
- -2.480-6.36%
Close Apr 4 16:00 ET
- 36.630
- +0.100+0.27%
Post 20:01 ET
74.20BMarket Cap22.41P/E (TTM)
37.980High36.270Low10.60MVolume37.740Open39.010Pre Close390.72MTurnover0.54%Turnover Ratio22.41P/E (Static)2.03BShares44.37652wk High4.14P/B71.78BFloat Cap31.37152wk Low1.52Dividend TTM1.96BShs Float44.376Historical High4.17%Div YieldTTM4.38%Amplitude6.306Historical Low36.847Avg Price1Lot Size
GlaxoSmithKline News
A Look Into GSK Inc's Price Over Earnings
RFK Jr. to Reinstate 20% of HHS Staff Laid off After DOGE Errors
Top Gap Ups and Downs on Thursday: UL, SHOP, NKE and More
New Study Shows Shingles Vaccine Linked To 20% Lower Dementia Risk, GSK Stock Pops
European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading
Today's Pre-Market Movers and Top Ratings | TSLA, AAPL, AZN and More
GlaxoSmithKline (GSK) Receives a Buy From Bernstein
U.K. Pharma to Have Some Share-Price Volatility But Long-Term Outlook Remains Intact -- Market Talk
Barclays Keeps GSK at Equal Weight, Sees Q1 Turnover in Line With Consensus
Shingles Vaccine Can Cut Risk of Developing Dementia - Study
SA Asks: How Will Changes at FDA Impact Vaccine Makers?
Unusual Options Activity: WSC, NUE and Others Attract Market Bets, WSC V/OI Ratio Reaches 69.9
Express News | Trump Administration Health Agency Firings Include Staff Overseeing Bird Flu Response
Top Midday Stories: Ford US Sales Fall 1.3% Year Over Year in Q1; Judge Denies Johnson & Johnson Unit's Bankruptcy Plan
Express News | Sources Do Not Expect Trump to Announce Pharma-Specific Tariffs Wednesday
Top FDA Vaccine Official Resigns Citing RFK Jr.'s 'Misinformation and Lies'
Market Chatter: GSK Wants Pharmaceutical Firms to Have More Access to UK Health Records
J.P. Morgan Sticks to Their Sell Rating for GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK.US) hopes the United Kingdom government will open the NHS database to promote drug development.
GlaxoSmithKline (GSK.US) is urging the United Kingdom government to allow pharmaceutical companies greater access to its public health databases in order to accelerate drug development and prevent the country from declining in the Global life sciences rankings.
Jim Cramer Says 'Buy and Put Away' GSK (GSK) for Its 4% Yield
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings